Compare ARDX & HIVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ARDX | HIVE |
|---|---|---|
| Founded | 2007 | 1987 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.1B |
| IPO Year | 2014 | 2017 |
| Metric | ARDX | HIVE |
|---|---|---|
| Price | $4.05 | $2.84 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 7 | 8 |
| Target Price | ★ $15.14 | $6.44 |
| AVG Volume (30 Days) | 2.6M | ★ 14.7M |
| Earning Date | 04-30-2026 | 02-17-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $2,607,000.00 | ★ $297,791,000.00 |
| Revenue This Year | $37.75 | $169.51 |
| Revenue Next Year | $34.24 | $39.45 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 158.32 |
| 52 Week Low | $4.71 | $1.73 |
| 52 Week High | $8.40 | $7.84 |
| Indicator | ARDX | HIVE |
|---|---|---|
| Relative Strength Index (RSI) | 34.44 | 41.16 |
| Support Level | N/A | $2.64 |
| Resistance Level | $6.47 | $3.40 |
| Average True Range (ATR) | 0.16 | 0.21 |
| MACD | 0.01 | 0.01 |
| Stochastic Oscillator | 12.09 | 28.57 |
Ardelyx Inc is a biopharmaceutical company developing and commercialize, first-in-class medicines that meet unmet medical needs. It has developed a platform that enabled the discovery of new biological mechanisms and pathways to develop potent and efficacious therapies that minimize the side effects and drug-drug interactions frequently encountered with traditional, systemically absorbed medicines. Its products Tenapanor, branded as IBSRELA, is used for the treatment of adults with IBS-C. Tenapanor, branded as XPHOZAH, is used to reduce serum phosphorus in adults with CKD on dialysis as add-on therapy in patients who have an inadequate response to phosphate binders or who are intolerant of any dose of phosphate binder therapy.
HIVE Digital Technologies Ltd is a sustainable-energy-focused digital infrastructure company that provides infrastructure solutions through the operation of Tier-1 and Tier-3 data centers. Its computing power is used for high-performance computing (HPC) and for generating hashrate sold to mining pools for cryptocurrency mining. The Company uses cash flow from its hashrate services business to support the expansion of its AI and HPC operations through its subsidiary. The Company focuses on Canada, Sweden, and Paraguay, where low-cost renewable power supports its operations and expansion. It operates in one segment with two revenue streams: the mining and sale of digital currencies and high-performance computing hosting. The majority of its revenue is generated from Bermuda.